2016 ANNUAL REPORT TO DONORS - Nemours

• And much, much more. The dedication of the PET/MR at Nemours/Alfred I. duPont Hospital for Children. Richard Finkel, MD, with Asher –one of the first patients with Type 1 SMA to benefit from nusinersen. James, an AML patient, has benefitted from studies conducted at Nemours. 2016 ANNUAL DONOR REPORT 4 ................
................